SEARCH

SEARCH BY CITATION

References

  • 1
    Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 2010; 87: 23.
  • 2
    Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 414.
  • 3
    Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875880.
  • 4
    Kumanyika SK, Obarzanek E, Stettler N, Bell R, Field AE, Fortmann SP et al. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the Expert Panel on Population and Prevention Science). Circulation 2008; 118: 428464.
  • 5
    Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741752.
  • 6
    Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248256.
  • 7
    Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 26832693.
  • 8
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc 2004; 292: 17241737.
  • 9
    Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753761.
  • 10
    Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond) 2007; 31: 569577.
  • 11
    Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 2008; 14: S1S83.
  • 12
    NICE. Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. London: National Institute for Health and Clinical Excellence, 2006.
  • 13
    Lakdawala M, Bhasker A. Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population: 9–10 August 2008, Trivandrum, India. Obes Surg 2010; 20: 929936.
  • 14
    Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010; 251: 399405.
  • 15
    Zimmet P, Campbell LV, Toomath R, Twigg S, Wittert G, Proietto J Bariatric surgery to treat severely obese patientswith type 2 diabetes: a consensus statement. Obes Res Clin Pract 2011; (in press).
  • 16
    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009; 52: 1730.
  • 17
    Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481486.
  • 18
    Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961969.
  • 19
    Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976–2004. Prev Med 2007; 45: 348352.
  • 20
    Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007; 30: 13741383.
  • 21
    Norris SL, Zhang X, Avenell A, Gregg E, Brown TJ, Schmid CH et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev 2005; CD004095.
  • 22
    Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; CD004096.
  • 23
    Farooqi IS, O’Rahilly S. Genetic factors in human obesity. Obes Rev 2007; 8: S37S40.
  • 24
    Swinburn B, Egger G. Prevention of type 2 diabetes. Prevention needs to reduce obesogenic environments. Br Med J 2001; 323: 997.
  • 25
    Schwartz MW, Porte D Jr. Diabetes, obesity, and the brain. Science 2005; 307: 375379.
  • 26
    Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 332: 621628.
  • 27
    Foo J, Toomath R, Wickremesekera SK, Bann S, Stubbs R. Bariatric surgery: a dilemma for the health system? N Z Med J 2010; 123: 1214.
  • 28
    Dixon JB. Referral for a bariatric surgical consultation: it is time to set a standard of care. Obes Surg 2009; 19: 641644.
  • 29
    Tripathy D, Chavez AO. Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep 2010; 10: 184191.
  • 30
    UKPDS. Overview of 6 years’ therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group, study 16. Diabetes 1995; 44: 12491258.
  • 31
    Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM et al. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010; 33: 983990.
  • 32
    Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359: 15651576.
  • 33
    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193203.
  • 34
    Trompet S, de Craen AJ, Mooijaart S, Stott DJ, Ford I, Sattar N et al. High innate production capacity of proinflammatory cytokines increases risk for death from cancer: results of the PROSPER Study. Clin Cancer Res 2009; 15: 77447748.
  • 35
    Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia 2002; 45: S23S28.
  • 36
    Roman G., Hancu N. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes. Horm Metab Res 2009; 41: 116122.
  • 37
    Bailey CJ, Del Prato S, Eddy D, Zinman B. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control. Int J Clin Pract 2005; 59: 13091316.
  • 38
    Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev 2009; CD003641.
  • 39
    Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg 2001; 25: 527531.
  • 40
    Rubino F, R’Bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 2010; 6: 102109.
  • 41
    Laferrere B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 24792485.
  • 42
    Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339350.
  • 43
    Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. J Am Med Assoc 2008; 299: 316323.
  • 44
    Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ et al. Body mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 22112219.
  • 45
    Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J et al. Body mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 10831096.
  • 46
    Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009; 10: 653662.
  • 47
    Peeters A, O’Brien PE, Laurie C, Anderson M, Wolfe R, Flum D et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg 2007; 246: 10281033.
  • 48
    Kolotkin RL, Crosby RD, Gress RE, Hunt SC, Adams TD. Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls. Surg Obes Relat Dis 2009; 5: 250256.
  • 49
    Dixon JB, Dixon ME, O’Brien PE. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res 2001; 9: 713721.
  • 50
    Zhuo X, Zhang P, Hoerger T. Lifetime cost of type 2 diabetes in the US. Presented at the American Diabetes Association meeting, 25–29 June 2010, Orlando, FL, USA. Abstract 0434-PP.
  • 51
    Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13: 1190, 215–357, iii–iv.
  • 52
    Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M. A study on the economic impact of bariatric surgery. Am J Manag Care 2008; 14: 589596.
  • 53
    National Institutes of Health (NIH). Website. Vol. 2010. Available at http://consensus.nih.gov/1991/1991gisurgeryobesity084html.htm Last accessed 18 December 2010.
  • 54
    Baur LA, Fitzgerald DA. Recommendations for bariatric surgery in adolescents in Australia and New Zealand. J Paediatr Child Health 2010; 46: 704707.
  • 55
    Inge TH, Krebs NF, Garcia VF, Skelton JA, Guice KS, Strauss RS et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004; 114: 217223.
  • 56
    Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350: 25492557.
  • 57
    Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009; 19: 16051611.
  • 58
    Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007; 142: 621632.
  • 59
    NHMRC. Clinical Practice Guidelines for the Management of Overweight and Obesity in Adults. Canberra: National Health and Medical Research Council, 2003.
  • 60
    Nguyen NT, Hinojosa M, Fayad C, Varela E, Wilson SE. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg 2007; 205: 248255.
  • 61
    Encinosa WE, Bernard DM, Du D, Steiner CA. Recent improvements in bariatric surgery outcomes. Med Care 2009; 47: 531535.
  • 62
    DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2010; 6: 347355.
  • 63
    ADA. Standards of medical care in diabetes—2010. Diabetes Care 2010; 33: S11S61.
  • 64
    Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 2009; 150: 94103.
  • 65
    Dixon JB, O’Brien P. Health outcomes of severely obese Type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 358363.
  • 66
    Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467484.
  • 67
    Rubino F, Marescaux J. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 111.
  • 68
    Strader AD, Vahl TP, Jandacek RJ, Woods SC, D’Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 2005; 288: E447E453.
  • 69
    Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741749.
  • 70
    Geloneze B, Geloneze SR, Fiori C, Stabe C, Tambascia MA, Chaim EA et al. Surgery for non-obese type 2 diabetic patients: an interventional study with duodenal–jejunal exclusion. Obes Surg 2009; 19: 10771083.
  • 71
    Lee HC, Kim MK, Kwon HS, Kim E, Song KH. Early changes in incretin secretion after laparoscopic duodenal–jejunal bypass surgery in type 2 diabetic patients. Obes Surg 2010; 20: 15301535.
  • 72
    DePaula AL, Stival A, Halpern A, Vencio S. Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI < 35: an analysis of 454 consecutive patients. World J Surg 2011; 35: 102108.
  • 73
    Kumar KV, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P et al. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther 2009; 11: 785789.
  • 74
    WHO. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157163.
  • 75
    WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1253.
  • 76
    Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care 2009; 32: 567574.
  • 77
    Hoerger TJ, Zhang P, Segel JE, Kahn HS, Barker LE, Couper S. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care 2010; 33: 19331939.
  • 78
    National Institutes of Health. Gastrointestinal surgery for severe obesity: NIH Consensus Development Conference Statement. Am J Clin Nutr 1992; 55: 615S619S.
  • 79
    Logue J, Thompson L, Romanes F, Wilson DC, Thompson J, Sattar N. Management of obesity: summary of SIGN guideline. Br Med J 2010; 340: c154.
  • 80
    DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis 2007; 3: 134140.
  • 81
    Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361: 445454.